CAS NO: | 1704638-35-6 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | NLRP3-IN-13 (Compound C77 in reference patent) is a selective and potentNLRP3inhibitor (IC50: 2.1 μM). NLRP3-IN-13 inhibitsNLRP3andNLRC4 inflammasomes, and inhibits NLRP3-mediated IL-1β production. NLRP3-IN-13 also inhibitsNLRP3ATPase activity. NLRP3-IN-13 can be used in the research of neuroinflammatory disorders[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
分子量 | 365.41 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C19H15N3O3S | ||||||||||||||||
CAS 号 | 1704638-35-6 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 50 mg/mL(136.83 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |